Mitomycin (mitomycin)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Mitomycin is an antineoplastic antibiotic produced by Streptomyces caespitosus.
USES: Mitomycin is used to treat various types of cancer (such as stomach/pancreas cancer). It works by slowing or stopping the growth of cancer cells.
Generic name: mitomycin
Pronunciation: (MYE-toe-MYE-sin)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Mitomycin
Indications
The following indications are listed for Mitomycin:
- Adenocarcinoma Of Pancreas
- Metastatic Gastric Cancer
Also known as: Metastatic Malignant Tumor Of Stomach, Pancreatic Adenocarcinoma.
Dosing
Dosage of mitomycin must be based on the clinical and hematologic response and tolerance of the patient and whether other myelosuppressive therapy is also being used to obtain optimum therapeutic results with minimum adverse effects. Clinicians should consult published protocols for the dosage of mitomycin and other chemotherapeutic agents and the method and sequence of administration.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
Mitomycin has produced teratogenic effects in animals. Safe use of mitomycin in pregnant women has not been established.
It is not known whether mitomycin is distributed in milk. Because of the potential for serious adverse reactions to mitomycin in nursing infants, nursing should be discontinued during mitomycin therapy.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.